james catto at University of Sheffield Medical School - Research Interests, Publications & Academic Profile

james catto

Professor of Urological Surgery

University of Sheffield Medical School

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Korean students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Epidemiology

40%

Biostatistics

40%

Bladder Cancer

70%

Oncology

40%

Urology

40%

Neoadjuvant Therapy

30%

Cancer Biology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Open

Genotype of Urothelial cancer: Stratified Treatment and Oncological outcomes (GUSTO): Phase II study

Open Date: 2021-12-01

Close Date: 2027-11-30

Grant: Close

Improving the outcomes from bladder cancer through genomic stratification and novel agents

Open Date: 2019-12-01

Close Date: 2024-11-30

Grant: Close

Masters in Mechanistic Biology

Open Date: 2011-09-30

Close Date: 2013-09-29

Articles17

Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT

Article Link

Year:

2024

Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial

Article Link

Year:

2024

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Article Link

Year:

2024

Blood Transfusion, Radical Cystectomy, and Cancer Recurrence: A New Look at an Old Story. Comment on Ladner et al. Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Soc. Int. Urol. J. 2024, 5, 202–213

Article Link

Year:

2024

Digital Tracking of Patients Undergoing Radical Cystectomy for Bladder Cancer: Daily Step Counts Before and After Surgery Within the iROC Randomised Controlled Trial

Article Link

Year:

2024

Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk

Article Link

Year:

2023

Diagnosis, treatment, and survival from kidney cancer: real‐world National Health Service England data between 2013 and 2019

Article Link

Year:

2023

Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019

Article Link

Year:

2023

Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer

Article Link

Year:

2023

An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer

Article Link

Year:

2023

Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study.

Article Link

Year:

2022

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer

Article Link

Year:

2022

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

Article Link

Year:

2022

Case of the month from the University of Sheffield, UK: Expediting definitive treatment in patients with invasive bladder cancer: an MRI‐guided pathway

Article Link

Year:

2022

Gene of the month: NKX3.1

Article Link

Year:

2022

Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial

Article Link

Year:

2022

Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non–muscle-invasive Bladder Cancer

Article Link

Year:

2021

Collaborators21

Sia Viborg Lindskrog

Aarhus University

DENMARK

Sarah Pirrie

University of Birmingham

UNITED KINGDOM

Lewis Quayle

Senior Lecturer in Data Science and Analytics

Sheffield Hallam University

UNITED KINGDOM

Taimur T. Shah

UNITED KINGDOM

Simon Dixon

University of Sheffield

UNITED KINGDOM

Peter Sasieni

King’s College London

UNITED KINGDOM

John Selph

The University of Alabama

UNITED STATES

Jan Adolfsson

Karolinska Institutet

SWEDEN

Richard Bryan

University of Birmingham

UNITED KINGDOM

Sue Mallett

University College London

UNITED KINGDOM

Athene Lane

Professor of Trials Research

University of Bristol

UNITED KINGDOM

Shomik Sengupta

Professor of Surgery

MONASH UNIVERSITY

AUSTRALIA

Hosam Serag

University Hospitals Birmingham NHS Foundation Trust

UNITED KINGDOM

Tarek Al-Hammouri

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

Graeme MacLennan

University of Aberdeen

UNITED KINGDOM

Jon Griffin

NIHR Clinical Lecturer in Histopathology

University of Sheffield

UNITED KINGDOM

Kerry Avery

University of Bristol

UNITED KINGDOM

Nicholas James

Professor of Prostate and Bladder Cancer Research

Institute of Cancer Research

UNITED KINGDOM

Juan Luis Vasquez

Associate Professor

University of Copenhagen

DENMARK

Gerald Verhaegh

Radboud University Medical Center

NETHERLANDS

Grant D. Stewart

UNITED KINGDOM

How do Korean students reach out?

Meet Kite AI